During June-July, Sabin’s Sustainable Immunization Financing Program is organizing a series of legislative workshops that will take place both at sub-regional (country clusters), national and subnational levels. Eleven SIF countries are participating.

Neglected tropical diseases (NTDs) were on the agenda this week at the Sixty-fifth session of the World Health Assembly (WHA) in Geneva, Switzerland.
 
A major milestone was reached when the WHA today approved a new resolution on elimination of schistosomiasis.
Today, the Rwandan Ministry of Health announced that they will introduce a new rotavirus vaccine nationwide.

Statement of Support for New Global Vaccine Action Plan

May 25, 2012

The Sabin Vaccine Institute applauds the decision made today by the Sixty-fifth World Health Assembly to endorse the Global Vaccine Action Plan (GVAP). As a research and advocacy organization devoted to ensuring that life-saving vaccines reach the people that need them most, we commend this action plan, which lays the groundwork for the discovery, development and equitable delivery of vaccines.

Sabin

Today, representatives at the Sixty-fifth World Health Assembly gave their support to a new Global Vaccine Action Plan (GVAP). WHA endorsement of the GVAP marks a major milestone towards universal access to immunization.

Sixty-fifth World Health Assembly focuses on universal coverage of healthcare

May 22, 2012

This week health ministers from around the world are meeting at the Sixty-fifth World Health Assembly (WHA) to discuss health issues that impact people everywhere. World Health Organization (WHO) Director-General Dr. Margaret Chan opened the meeting on Monday by calling for universal health coverage.

“Universal health coverage is the best way to cement the gains made during the previous decade. It is the ultimate expression of fairness. This is the anchor for the work of WHO as we move forward,” said Dr. Chan.

Sabin

This month, the Sabin Vaccine Institute will begin a Phase-1 clinical trial in Washington, DC to further investigate the Na-GST-1 human hookworm vaccine candidate.

Dengue outbreaks occur in countries throughout the world on an all too frequent basis. One of the latest countries to experience an outbreak of the disease is the Philippines.

Pages